Employer record no. 5523
Ultragenyx Pharmaceutical, Inc.
US DOL LCA disclosure data, FY2020 to FY2026
Total LCA filings
83
Certified
72
Denied
0
FY2025 filings
11
Filings by fiscal year
* partial fiscal year; quarters still being published by DOL
Peer rank
#372 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2020 | 4 | 4 | 0 | $115,248 | $101,525 |
| FY2021 | 17 | 17 | 0 | $151,140 | $140,474 |
| FY2022 | 17 | 16 | 0 | $139,158 | $133,291 |
| FY2023 | 17 | 13 | 0 | $130,263 | $115,642 |
| FY2024 | 10 | 9 | 0 | $156,368 | $140,154 |
| FY2025 | 11 | 8 | 0 | $170,026 | $165,337 |
| FY2026 * | 7 | 5 | 0 | $129,419 | $122,670 |
What they file for
- senior associate, regulatory operations$85,8094
- senior director, cmc quality assurance$224,7934
- associate director, business operations$200,0002
- associate director, clinical programs$176,0302
- manager, quality assurance$135,0142
- medical director, global clinical development (neurology)$262,1222
- research associate ii$82,0142
- scientist i, upstream process characterization$105,3942
Where
- bedford, ma20
- brisbane, ca13
- woburn, ma13
- novato, ca12
- cambridge, ma6
- south san francisco, ca4
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for Ultragenyx Pharmaceutical, Inc. and any other employer they watch.
Certification rate 86.7%How these numbers are computed